ELUTIA INC. — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2021-06-07

Reporting Person: HighCape Capital, L.P. (N/A)
Reporting Person: HIGHCAPE PARTNERS, L.P. (10% Owner)
Reporting Person: HIGHCAPE PARTNERS QP, L.P. (10% Owner)
Reporting Person: HighCape Partners GP, LLC (10% Owner)
Reporting Person: HighCape Partners GP, L.P. (10% Owner)
Reporting Person: HighCape Co-Investment Vehicle I, LLC (10% Owner)
Reporting Person: HighCape Co-Investment Vehicle II, LLC (Director, 10% Owner)
Reporting Person: HighCape Capital, LLC (10% Owner)
Reporting Person: Zuga Matt (Director, 10% Owner)
Reporting Person: RAKIN KEVIN (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Stock Option (Right to Buy)	$6.28	A	22090	Acquired	2032-06-06	Class A Common Stock (22090)	Indirect
2022-06-07	Stock Option (Right to Buy)	$6.28	A	22090	Acquired	2032-06-06	Class A Common Stock (22090)	Indirect

Footnotes

F1: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.

F2: Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors.

F3: Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors.